Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis
- 14 November 2011
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1237 (1) , 5-10
Abstract
The most important milestone in understanding a genetic disease is the identification of the causative mutation. However, such knowledge is often insufficient to decipher the pathophysiology of the disorder or to effectively treat those affected. Fibrodysplasia ossificans progressiva (FOP) is a rare, disabling, genetic disease of progressive heterotopic endochondral ossification (HEO) enabled by missense mutations that promiscuously and provisionally activate ACVR1/ALK2, a bone morphogenetic protein (BMP) type I receptor, in all affected individuals. While activating mutations of the ACVR1/ALK2 receptor are necessary, disease activity and progression also depend on altered cell and tissue physiology. Recent findings identify inflammatory and immunological factors, vascular‐derived mesenchymal stem cells, and a hypoxic lesional microenvironment that trigger, promote, and enable episodic progression of FOP in the setting of the genetic mutation. Effective therapies for FOP will need to consider these seminal pathophysiologic interactions.Keywords
This publication has 38 references indexed in Scilit:
- Conversion of vascular endothelial cells into multipotent stem-like cellsNature Medicine, 2010
- Applications of small molecule BMP inhibitors in physiology and diseaseCytokine & Growth Factor Reviews, 2009
- Smad signaling in skeletal development and regenerationCytokine & Growth Factor Reviews, 2009
- The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signalingCytokine & Growth Factor Reviews, 2009
- Circulating Osteogenic Precursor Cells in Heterotopic Bone FormationStem Cells, 2009
- When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP)Drug Discovery Today: Therapeutic Strategies, 2009
- Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1Human Mutation, 2008
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP)Journal of Bone and Mineral Metabolism, 2008
- Fibrodysplasia ossificans progressivaBest Practice & Research Clinical Rheumatology, 2008